Li-Min Wang

3PUBLICATIONS
20CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 18, 2026
Development of SDP0505: a first-in-class HER3 × c-Met bispecific ADC, demonstrates potent antitumor activity in EGFR TKI-resistant NSCLC, CRC, and beyond.

|Aug 26, 2025
SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile.

Li-Min Wang, Changyong Yang, Xing Sun

|Jan 18, 2023
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance.

Li-Min Wang, Pingyuan Wang, Xiao-Min Chen

Pageof 1

Frequent Collaborators

2 joint publications

Wei Zhang

1 joint publications

Xiao-Min Chen

1 joint publications

Hui Yang

1 joint publications

Hua-Dong Chen